Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection
Authors:
Higashio H, Nishimura N, Ishizaki H, Miyoshi J, Orita S, Sakane A, Sasaki T
In:
J Immunol (2008) 180(7): 4774-84
Categories:
Transfection
Authors:
Zhang J, Suzuki K, Hitomi T, Siraganian RP
In:
J Biol Chem (2007) 282(52): 37669-77
Categories:
Transfection
Authors:
Tshori S, Sonnenblick A, Yannay-Cohen N, Kay G, Nechushtan H, Razin E
In:
Mol Cell Biol (2007) 27(11): 3911-9
Categories:
Transfection
Authors:
Nanamori M, Chen J, Du X, Ye RD
In:
J Immunol (2007) 178(1): 416-27
Categories:
Transfection
Authors:
Csutora P, Zarayskiy V, Peter K, Monje F, Smani T, Zakharov SI, Litvinov D, Bolotina VM
In:
J Biol Chem (2006) 281(46): 34926-35
Categories:
Transfection
Authors:
Fattakhova G, Masilamani M, Borrego F, Gilfillan AM, Metcalfe DD, Coligan JE
In:
Traffic (2006) 7(6): 673-85
Categories:
Transfection
Authors:
Levy C, Lee YN, Nechushtan H, Schueler-Furman O, Sonnenblick A, Hacohen S and Razin E
In:
Blood (2006) 107(7): 2839-45
Categories:
Transfection
Authors:
Gaudreault E, Thompson C, Stankova J and Rola-Pleszczynski M
In:
J Immunol (2005) 174(6): 3617-3625
+ Show All